Invion Ltd. (AU:IVX) has released an update.
Invion Limited has announced the issuance of 100,000,000 new shares at $0.001 each, without investor disclosure under the Corporations Act. The life-science company, known for its research and development of Photosoft™ technology for cancer treatment, confirms compliance with all necessary regulatory provisions as of the date of the announcement.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.
